Infectious Diseases News and Research

RSS

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

The gut microbiome - the collection of bacteria, viruses, fungi, and other microorganisms that reside in our gastrointestinal tracts - can impact us in a variety of different ways, from our metabolism to our mood.

9 Sep 2021

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.

7 Sep 2021

Researchers uncover underlying metabolic changes that are linked to COVID-19 severity

COVID-19 patients have differing immune responses that lead to disease outcomes ranging from asymptomatic SARS-CoV-2 infection to death.

6 Sep 2021

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

Recently, researchers found the risk of being hospitalized was two times higher for people with the Delta variant as compared to those with the Alpha variant.

6 Sep 2021

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

A new study provides evidence of the correlation and estimated the period between the generation interval and incubation period of SARS-CoV-2.

5 Sep 2021

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

In a recent study published in Reviews in Endocrine and Metabolic Disorders, the researchers discuss the extra-pulmonary manifestations of COVID-19.

5 Sep 2021

Weill Cornell receives NIH support to advance TB research

Tuberculosis (TB) is one of the deadliest infectious diseases in history and one of the few that naturally infects only humans.

4 Sep 2021

Your covid game plan: Are stadiums safe?

The college football season is kicking into high gear, the National Football League season starts Sept. 9, and the baseball pennant races are heating up. For the first time since 2019, nearly all stadiums will be fully open to fans.

3 Sep 2021

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases (NCID) and Singapore General Hospital (SGH), have discovered a simple and rapid method to measure the T-cell immune response to the SARS-CoV-2 virus, which causes COVID-19.

3 Sep 2021

People who received two vaccine doses have lower odds of experiencing long COVID

People who tested positive for SARS-CoV-2 after one or two vaccine doses had significantly lower odds of severe disease or hospitalization than unvaccinated people, according to a large-scale study investigating COVID-19 breakthrough infections published in The Lancet Infectious Diseases journal.

2 Sep 2021

World renowned immunologist named chief of Feinberg's Division of Allergy and Immunology

Stephanie Eisenbarth, MD, PhD, has been named chief of Feinberg's Division of Allergy and Immunology in the Department of Medicine, and director of the newly formed Center for Human Immunobiology.

2 Sep 2021

Double vaccination reduces the risk of Long COVID by almost half

Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.

2 Sep 2021

International taskforce recommends neurocognitive tests to harmonize assessment of long COVID

An international taskforce created by a UNSW Science psychology researcher has recommended a set of neurocognitive and mental health questionnaires to harmonize the assessment of patients with long COVID.

2 Sep 2021

Immune cells present in tumors from head and neck cancer patients, study reports

A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the major targets of immune checkpoint inhibitors are present in tumors from head and neck cancer patients.

2 Sep 2021

Experts show waning effectiveness of COVID-19 vaccines over time

In a letter to The New England Journal of Medicine, publishing online September 1, 2021, an interdisciplinary team of physicians and public health experts at University of California San Diego measured the effectiveness of COVID-19 mRNA vaccines among health workers at UC San Diego Health, most notably during the emergence of the highly transmissible delta virus variant and coincident with the end of the state's mask mandate, allowing fully vaccinated persons to forgo face coverings in most places.

1 Sep 2021

COVID-19 associated mucormycosis cases in India

India continues to grapple with the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the country has reported over one million new cases for the past 28 days.

31 Aug 2021

Association between COVID-19 mitigation measures and preterm birth rate in China

A new study published in British Medical Journal Global Health addresses the effect of COVID-19 mitigation measures on the preterm birth rate in China.

31 Aug 2021

Key cross-government effort underway to ensure Afghans arriving in the UK receive support

A significant cross-government effort is underway, dubbed 'Operation Warm Welcome', to ensure Afghans arriving in the UK receive the vital support they need to rebuild their lives, find work, pursue education and integrate into their local communities.

31 Aug 2021

Researchers identify biomarkers for rare, serious complication in children with COVID-19

The study focused on multisystem inflammatory syndrome in children (MIS-C), an inflammatory response involving multiple organs that can occur weeks after infection with SARS-CoV-2, the virus that causes COVID-19.

31 Aug 2021

$1.3 million in NIH funding to enable drug delivery technology research

Two National Institute of Health grants totaling over $1.3 million will enable research into antibody-mediated drug delivery technology for the treatment of cancer and autoimmune disorders. L. Nathan Tumey, assistant professor of pharmaceutical sciences at Binghamton University, State University of New York, is the Principal Investigator on both grants - $1.2 million from the National Institute of General Medical Sciences and $150,000 from the National Institute of Allergy and Infectious Diseases.

31 Aug 2021

Infectious Diseases News and Research

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

Researchers uncover underlying metabolic changes that are linked to COVID-19 severity

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

Weill Cornell receives NIH support to advance TB research

Your covid game plan: Are stadiums safe?

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

People who received two vaccine doses have lower odds of experiencing long COVID

World renowned immunologist named chief of Feinberg's Division of Allergy and Immunology

Double vaccination reduces the risk of Long COVID by almost half

International taskforce recommends neurocognitive tests to harmonize assessment of long COVID

Immune cells present in tumors from head and neck cancer patients, study reports

Experts show waning effectiveness of COVID-19 vaccines over time

COVID-19 associated mucormycosis cases in India

Association between COVID-19 mitigation measures and preterm birth rate in China

Key cross-government effort underway to ensure Afghans arriving in the UK receive support

Researchers identify biomarkers for rare, serious complication in children with COVID-19

$1.3 million in NIH funding to enable drug delivery technology research

NGS for Infectious Disease Surveillance eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News